Great perspective on future challenges and opportunities to overcome this pandemic!

Thx for questions and to our moderator and speakers!

Very happy this is out! We identified new specific profibrotic macrophage markers and small molecules that reverted their gene expression. Always great to work with the #DreamTeam #IPFCellAtlas! Thanks all for your efforts and guidance!

Given the global impact of COVID-19 pneumonia on patients, we are disappointed that the REMDACTA study did not meet its endpoints businesswire.com/news/home/2021…

Finally! Our Human Lung Endothelial Cell Atlas is out! Everything you wanted to know about lung endothelial cells - new insights, detailed descriptions & confirmations in mice & humans. Kudos Jonas Schupp Ivan Rosas & team! #ScRNAseq #OpenAccess @yale ahajournals.org/doi/10.1161/CI…

REMDACTA Trial: Tocilizumab + remdesivir vs remdesivir alone in severe #COVID19 pneumonia? NO treatment benefit. Median time from randomization to 🏥 discharge or "ready for discharge" 14 days for both groups. 💉Results rdcu.be/cy6pU 💉Editorial bit.ly/2YBadvd

Literature laureate Gabriel García Márquez’s international breakthrough came in 1967 with the novel 'Cien años de soledad' ('One Hundred Years of Solitude'). He is one of the foremost interpreters of magical realism in literature. Learn more here: bit.ly/3fRg054

Tocilizumab + remdesivir vs remdesivir alone in severe #COVID19 pneumonia? NO benefit. Median time from randomization to 🏥 discharge or ready for discharge 14 days for both groups 💉REMDACTA RCT rdcu.be/cAROZ 💉Editorial rdcu.be/cAS30 Below visual abstract ⬇️

COPD Cell Atlas is finally out! Read “Characterization of the #COPD alveolar niche using single-cell RNA sequencing” for many exciting & novel insights! Kudos Maor Sauler John McDonough Ivan Rosas, Pascal N. Timshel all others, for this amazing effort. See 🧵below nature.com/articles/s4146…

Read about Altered gene expression and cell interactions involved in COPD here: bcm.edu/news/altered-g…

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. pubmed.ncbi.nlm.nih.gov/34813355/

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease medrxiv.org/cgi/content/sh… #medRxiv

Center for advanced #lung disease and lung transplantation has a new home! World class care for patients with #ild, advanced lung diseases and🫁 txp BCM Department of Medicine BCM PCCSM section BCM Advanced Lung Diseases Pulmonary Fibrosis Foundation Lung Transplant Fdtn Puneet Garcha, MD, MBA Ivan Rosas Gabriel Loor Gloria Li St. Luke's Health

A milestone for BCM PCCSM section BCM Lung Institute BCM Department of Medicine! The #ILD clinic and #lungtransplant program has a new name, new meaning and a renewed mission-comprehensive patient care by a world class team! Ivan Rosas Puneet Garcha, MD, MBA Gloria Li Gabriel Loor St. Luke's Health Texas Medical Center

Read about New drug potentially identified to expand rheumatoid arthritis-associated interstitial lung disease treatment here: bcm.edu/news/new-drug-…

The last 30 minutes of the second day of the virtual #PFStakeHolderSummit2022 still 107 (!) attendees - concluded with a superb discussion about better, faster clinical trial designs for #PulmonaryFibrosis. Cannot wait to see them start!!! #CurePF

Congrats to an amazing team!